Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ajooni BiotechNSE:AJOONI +2.39%64 PEG Ratio is 7.42 as of Aug. 17, 2026, which is 540% above its 10-year median of 1.16. GuruFocus rates NSE:AJOONI with a GF Score™ of 64/100 and a GF Value™ of ₹6.26 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 795 Consumer Packaged Goods companies, Ajooni Biotech ranks worse than 88.18% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Ajooni Biotech's PEG Ratio or its related term are showing as below:
NSE:AJOONI'
s PEG Ratio Range Over the Past 10 Years
Min: 0.12 Med: 1.16 Max: 8.93
Current: 7.42
During the past 13 years, Ajooni Biotech's highest PEG Ratio was 8.93. The lowest was 0.12. And the median was 1.16.
NSE:AJOONI's PEG Ratio is ranked worse than 88.18% of 795
companies
in the Consumer Packaged Goods industry
Industry Median: 1.34
vs NSE:AJOONI: 7.42
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Ajooni Biotech PEG Ratio Related Terms
Ajooni Biotech PEG Ratio Historical Data
* Premium members only.
The historical data trend for Ajooni Biotech's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Ajooni Biotech's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ajooni Biotech PEG Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Ajooni Biotech's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Ajooni Biotech's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Ajooni Biotech (NSE:AJOONI) has a PEG Ratio of 7.42 as of Aug. 17, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Ajooni Biotech and its competitors. This is 540% above median its historical median of 1.16. Over the past decade, Ajooni Biotech's PEG Ratio has ranged from 0.12 to 8.93. According to the industry distribution chart, Ajooni Biotech ranks #701 out of 795 companies in the Consumer Packaged Goods industry, placing it in the top 88.2%.
Is Ajooni Biotech's PEG Ratio too high?
Ajooni Biotech's current PEG Ratio of 7.42 is 540% above median its 10-year median of 1.16. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 8.93. The Consumer Packaged Goods industry median PEG Ratio is 1.34. Ajooni Biotech's value of 7.42 is 453.7% above this industry median. Based on the distribution chart, Ajooni Biotech ranks #701 out of 795 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Ajooni Biotech has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ajooni Biotech's PEG Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Ajooni Biotech ranks #701 out of 795 companies for PEG Ratio. This places Ajooni Biotech in the lower half of its industry. The industry median PEG Ratio is 1.34. Ajooni Biotech's value of 7.42 is 453.7% above this benchmark. Historically, Ajooni Biotech's own PEG Ratio has ranged from 0.12 to 8.93 over the past decade. While the company's 10-year median is 1.16 vs. the industry median of 1.34, Ajooni Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Consumer Packaged Goods company?
The median PEG Ratio among Consumer Packaged Goods companies is 1.34, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ajooni Biotech's current PEG Ratio of 7.42 is 453.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Ajooni Biotech and its competitors. For the Consumer Packaged Goods industry, the median PEG Ratio is 1.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ajooni Biotech's current PEG Ratio is 7.42, which is 540% above median its own 10-year median of 1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ajooni Biotech stock overvalued right now?
Based on GuruFocus' analysis, Ajooni Biotech (NSE:AJOONI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹6.26, compared to a current price of ₹3.86 — trading 38.3% below its estimated fair value. The current PEG Ratio is 7.42, which is 540% above median its 10-year median of 1.16 and 453.7% above the Consumer Packaged Goods industry median of 1.34. Ajooni Biotech's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Ajooni Biotech (NSE:AJOONI), the current PEG Ratio is 7.42 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ajooni Biotech (NSE:AJOONI) Overvalued in 2026?
Based on GuruFocus' analysis, Ajooni Biotech stock appears to be undervalued.
The current stock price of ₹3.86 is trading 38.3% below its estimated GF Value™ of ₹6.26.
GuruFocus considers Ajooni Biotech to be Possible Value Trap.
Key valuation signals for NSE:AJOONI:
PEG Ratio: 7.42 (540% above median its 10-year median of 1.16)
GF Value™: ₹6.26 vs. price of ₹3.86 (38.3% below fair value)
Industry Position: 453.7% above the Consumer Packaged Goods median (#701 of 795)
No single metric tells the full story. See the NSE:AJOONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ajooni Biotech Ltd is engaged in providing animal health care solutions dedicated to improving the productivity of Dairy farmers and sustainably increasing livestock yields. The company's products of cattle feed include Gold Pashu Aahar, Buff Plus, 3 Star, 4 Star, Calf Starter, & Transition Plus, and its feed supplements include Calvit, Batisa, Liv, Min, and other products. It derives majority portion of the revenue from the manufacturing of cattle feed. The company operates only in India.
64GF Score
Get the complete analysis for NSE:AJOONI
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AJOONI has been successfully added to your 
